Use of mutagenesis to probe IGF-binding protein structure/function relationships.
暂无分享,去创建一个
[1] D. Clemmons. IGF binding proteins and their functions , 1993, Molecular reproduction and development.
[2] M. Rechler,et al. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs. , 1995, Endocrinology.
[3] R. Brommage,et al. Benefit of systemically administered rhIGF‐I and rhIGF‐I/IGFBP‐3 on cancellous bone in ovariectomized rats , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] D. Andress. Heparin Modulates the Binding of Insulin-like Growth Factor (IGF) Binding Protein-5 to a Membrane Protein in Osteoblastic Cells (*) , 1995, The Journal of Biological Chemistry.
[5] R. Baxter,et al. Insulin-like growth factor-binding protein from human plasma. Purification and characterization. , 1986, The Journal of biological chemistry.
[6] Y. Hasegawa,et al. Characterization of urinary insulin-like growth factor binding proteins. , 1992, The Journal of clinical endocrinology and metabolism.
[7] J. Fowlkes,et al. Insulin-like Growth Factor (IGF)-binding Protein-3 (IGFBP-3) Functions as an IGF-reversible Inhibitor of IGFBP-4 Proteolysis (*) , 1995, The Journal of Biological Chemistry.
[8] J. Wallace,et al. The Insulin-like Growth Factor (IGF) Binding Site of Bovine Insulin-like Growth Factor Binding Protein-2 (bIGFBP-2) Probed by Iodination* , 1996, The Journal of Biological Chemistry.
[9] D. Clemmons,et al. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. , 1996, Endocrinology.
[10] D. Clemmons,et al. Inhibition of IGFBP‐5 binding to extracellular matrix and IGF‐I–stimulated DNA synthesis by a peptide fragment of IGFBP‐5 , 1998, Journal of cellular biochemistry.
[11] T. Schoen,et al. Vitreous and aqueous humors contain a latent proteinase activity that abolishes IGF binding to specific IGF binding proteins. , 1995, Current eye research.
[12] S. Mohan,et al. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. , 2000, Archives of biochemistry and biophysics.
[13] M. Binoux,et al. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. , 1990, The Journal of clinical endocrinology and metabolism.
[14] D. Clemmons,et al. Insulin‐like growth factor binding protein secretion by muscle cells: Effect of cellular differentiation and proliferation , 1988, Journal of cellular physiology.
[15] G. Werther,et al. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. , 1997, Endocrinology.
[16] M. T. Brewer,et al. Cloning, characterization, and expression of a human insulin-like growth factor binding protein. , 1988, Biochemical and biophysical research communications.
[17] M. Yoshida,et al. Binding Sites and Binding Properties of Binary and Ternary Complexes of Insulin-like Growth Factor-II (IGF-II), IGF-binding Protein-3, and Acid-labile Subunit* , 1997, The Journal of Biological Chemistry.
[18] R. Baxter,et al. A Central Domain Binding Site in Insulin-Like Growth Factor Binding Protein-5 for the Acid-Labile Subunit. , 2000, Endocrinology.
[19] X. Lu,et al. Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. , 1995, Journal of molecular endocrinology.
[20] J. Wallace,et al. Localization of an Insulin-like Growth Factor (IGF) Binding Site of Bovine IGF Binding Protein-2 Using Disulfide Mapping and Deletion Mutation Analysis of the C-terminal Domain* , 1998, The Journal of Biological Chemistry.
[21] T. Nam,et al. Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts. , 1996, Endocrinology.
[22] D. Clemmons,et al. Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions* , 2000, The Journal of Biological Chemistry.
[23] S. Mohan,et al. Structure-Function Analysis of the Human Insulin-like Growth Factor Binding Protein-4* , 1998, The Journal of Biological Chemistry.
[24] D. Leroith,et al. Molecular and Cellular Biology of Insulin-like Growth Factors and Their Receptors , 1989, Springer US.
[25] J. Merryweather,et al. Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia. , 1990, The Journal of biological chemistry.
[26] P. Monget,et al. Proteolytic activity is involved in changes in intrafollicular insulin-like growth factor-binding protein levels during growth and atresia of ovine ovarian follicles. , 1996, Endocrinology.
[27] T. Chard,et al. Development of a radioimmunoassay for oxytocin. , 1969, The Journal of endocrinology.
[28] P. Newcomb,et al. Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. , 1999, Journal of molecular endocrinology.
[29] E. Froesch,et al. Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein. , 1975, Archives of biochemistry and biophysics.
[30] U. Stenman,et al. Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. , 1993, The Journal of clinical endocrinology and metabolism.
[31] D. Clemmons,et al. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Holly,et al. Insulin-like growth factors (IGFs) and IGF-binding proteins in human skin interstitial fluid. , 1995, The Journal of clinical endocrinology and metabolism.
[33] The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3. , 2000, Endocrinology.
[34] F. Garrouste,et al. Surface‐bound plasmin induces selective proteolysis of insulin‐like‐growth‐factor (IGF)‐binding protein‐4 (IGFBP‐4) and promotes autocrine IGF‐II bio‐availability in human colon‐carcinoma cells , 1997, International journal of cancer.
[35] A. Moses,et al. Further characterization of growth hormone-dependent somatomedin-binding proteins in rat serum and demonstration of somatomedin-binding proteins produced by rat liver cells in culture. , 1979, Endocrinology.
[36] B. Riggs,et al. Alterations in insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis in transformed osteoblastic cells. , 1995, Endocrinology.
[37] S. Mohan,et al. Bioactivity of a 29-Kilodalton Insulin-Like Growth Factor Binding Protein-3 Fragment Present in Excess in Chronic Renal Failure Serum , 1997, Pediatric Research.
[38] R. Baxter,et al. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. , 1988, Biochemical and biophysical research communications.
[39] D. Clemmons,et al. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells. , 1995, Endocrinology.
[40] M. Binoux,et al. The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. , 1997, Endocrinology.
[41] C. Conover,et al. Cleavage Analysis of Insulin-like Growth Factor (IGF)-dependent IGF-binding Protein-4 Proteolysis and Expression of Protease-resistant IGF-binding Protein-4 Mutants (*) , 1995, The Journal of Biological Chemistry.
[42] D. Clemmons,et al. Identification of the Extracellular Matrix Binding Sites for Insulin-like Growth Factor-binding Protein 5* , 1996, The Journal of Biological Chemistry.
[43] R. Baxter,et al. Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins. , 1986, Biochemical and biophysical research communications.
[44] J. Wallace,et al. Alanine Screening Mutagenesis Establishes Tyrosine 60 of Bovine Insulin-like Growth Factor Binding Protein-2 as a Determinant of Insulin-like Growth Factor Binding* , 1998, The Journal of Biological Chemistry.
[45] D. Andress. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. , 1998, American Journal of Physiology. Endocrinology and Metabolism.
[46] D. Powell,et al. Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. , 1988, Molecular endocrinology.
[47] E. Zwarthoff,et al. Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity. , 1991, Molecular endocrinology.
[48] C. Stroh,et al. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. , 1994, Endocrinology.
[49] D. Clemmons,et al. Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin. , 1983, Journal of Clinical Endocrinology and Metabolism.
[50] D. Clemmons,et al. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults. , 1992, The Journal of clinical endocrinology and metabolism.
[51] C. Conover,et al. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action. , 1996, Endocrinology.
[52] R. Baxter,et al. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[53] D. Clemmons,et al. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. , 1998, Molecular biology of the cell.
[54] L. Bach,et al. Identification of O-glycosylation sites and partial characterization of carbohydrate structure and disulfide linkages of human insulin-like growth factor binding protein 6. , 1998, Biochemistry.
[55] R. Koistinen,et al. Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. , 1986, Endocrinology.
[56] J. Wallace,et al. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. , 1993, The Biochemical journal.
[57] M. Binoux,et al. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. , 1996, Endocrinology.
[58] D. Clemmons,et al. Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101. , 1993, The Journal of biological chemistry.
[59] D. Clemmons,et al. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[60] J. Beattie,et al. Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I. , 1999, Journal of molecular endocrinology.
[61] F. Pralong,et al. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. , 1993, The Journal of endocrinology.
[62] N. Skakkebæk,et al. Serum concentrations of free and total insulin‐like growth factor‐I, IGF binding proteins ‐1 and‐3 and IGFBP‐3 protease activity in boys with normal or precocious puberty , 1996, Clinical endocrinology.
[63] B. Roth,et al. Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants. , 1992, European journal of biochemistry.
[64] D. Clemmons,et al. Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2. , 1995, Circulation research.
[65] N. Ling,et al. Characterization of an insulin-like growth factor binding protein (IGFBP-4) produced by the B104 rat neuronal cell line: chemical and biological properties and differential synthesis by sublines. , 1991, Endocrinology.
[66] M. Czech,et al. Purification and amino-terminal sequence of an insulin-like growth factor-binding protein secreted by rat liver BRL-3A cells. , 1986, The Journal of biological chemistry.
[67] P. Campbell,et al. Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I binding. , 1997, The American journal of physiology.
[68] K. Hall,et al. Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid. , 1984, European journal of biochemistry.
[69] S. Mohan,et al. Studies on the Role of Human Insulin‐like Growth Factor‐II (IGF‐II)‐Dependent IGF Binding Protein (hIGFBP)‐4 Protease in Human Osteoblasts Using Protease‐Resistant IGFBP‐4 Analogs , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[70] O. Itkonen,et al. Insulin-like growth factor-binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis. , 1990, Biochemical and biophysical research communications.
[71] M. Rechler,et al. Human insulin-like growth factor binding protein-6 is O-glycosylated. , 1992, Biochemical and biophysical research communications.
[72] D. Clemmons,et al. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[73] E. Spencer,et al. A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3. , 1995, Progress in growth factor research.
[74] P. Cohen,et al. Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis , 2000, Journal of cellular physiology.
[75] D. Powell,et al. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3. , 1998, American journal of physiology. Endocrinology and metabolism.
[76] R. Rosenfeld,et al. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. , 1993, The Journal of biological chemistry.
[77] S. Mohan,et al. Intact insulin‐like growth factor binding protein‐5 (IGFBP‐5) associates with bone matrix and the soluble fragments of IGFBP‐5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2‐treatment , 1996, Journal of cellular physiology.
[78] L. Bach,et al. The N-terminal Disulfide Linkages of Human Insulin-like Growth Factor-binding Protein-6 (hIGFBP-6) and hIGFBP-1 Are Different as Determined by Mass Spectrometry* , 1999, The Journal of Biological Chemistry.
[79] D. Clemmons,et al. Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. Evidence in a rabbit ear dermal ulcer model. , 1996, The Journal of clinical investigation.
[80] D. Andress,et al. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. , 1993, Biochemical and biophysical research communications.
[81] R. Baxter,et al. Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. , 1986, The Journal of clinical investigation.
[82] M. Gidlund,et al. Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-1 but not IGF-2-induced cell proliferation. , 1992, Experimental cell research.
[83] R. Baxter,et al. Regulation of insulin-like growth factor (IGF) binding protein-3 phosphorylation by IGF-I. , 1995, Endocrinology.
[84] M. Freemark,et al. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. , 1992, Endocrinology.
[85] J. Weiler,et al. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. , 1995, Growth regulation.
[86] V. Mukku,et al. Identification of the major sites of phosphorylation in IGF binding protein‐3 , 1994, Journal of cellular biochemistry.
[87] W. A. Müller,et al. Non-suppressible insulin-like activity of human serum. I. Physicochemical properties, extraction and partial purification. , 1966, Biochimica et biophysica acta.
[88] D. Clemmons,et al. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes. , 1994, The Journal of biological chemistry.
[89] R. Baxter,et al. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. , 1989, The Journal of biological chemistry.
[90] M. Binoux,et al. Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity. , 1997, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[91] D. Clemmons,et al. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. , 1988, The Journal of clinical endocrinology and metabolism.
[92] M. Binoux,et al. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. , 1986, Analytical biochemistry.
[93] M. Rechler,et al. Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factors. , 1989, The Journal of biological chemistry.
[94] R. Baxter,et al. Phosphorylation of insulin-like growth factor binding proteins , 1997, Molecular and Cellular Endocrinology.
[95] R. Baxter,et al. Characterization of truncated insulin-like growth factor-binding protein-2 in human milk. , 1997, Endocrinology.
[96] D. Clemmons,et al. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. , 1992, The Journal of biological chemistry.
[97] J. Beattie,et al. Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5. , 2000, Journal of molecular endocrinology.
[98] R. Rabkin,et al. Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. , 1997, Endocrinology.
[99] C. Conover,et al. Regulation of insulin‐like growth factor binding protein 4 by a specific insulin‐like growth factor binding protein 4 proteinase in normal human osteoblast‐like cells: Implications in bone cell physiology , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[100] L. Giudice,et al. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. , 1990, The Journal of clinical endocrinology and metabolism.
[101] W. Wood,et al. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. , 1988, Molecular endocrinology.
[102] R. Baxter,et al. Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin β Subunit* , 2000, The Journal of Biological Chemistry.
[103] D. Clemmons,et al. Characterization of insulin‐like growth factor binding protein‐1 kinases from human hepatoma cells , 1996, Journal of cellular biochemistry.
[104] D. Clemmons,et al. Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4 , 1995, The Journal of Biological Chemistry.
[105] D. Clemmons,et al. Purified preparations of the amniotic fluid-derived insulin-like growth factor-binding protein contain multimeric forms that are biologically active. , 1989, Endocrinology.
[106] D. Clemmons,et al. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. , 1991, The Journal of clinical endocrinology and metabolism.
[107] D. Clemmons,et al. Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.
[108] R. Baxter,et al. Glycosaminoglycans inhibit formation of the 140 kDa insulin-like growth factor-binding protein complex. , 1990, The Biochemical journal.
[109] R. Valcavi,et al. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. , 1993, The Journal of clinical endocrinology and metabolism.
[110] M. Rechler,et al. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. , 1993, The Journal of biological chemistry.
[111] S. Drop,et al. Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay. , 1984, The Journal of clinical endocrinology and metabolism.
[112] D. Andress,et al. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. , 1992, The Journal of biological chemistry.
[113] S. Mohan,et al. Studies on the Mechanisms by Which Insulin-like Growth Factor (IGF) Binding Protein-4 (IGFBP-4) and IGFBP-5 Modulate IGF Actions in Bone Cells (*) , 1995, The Journal of Biological Chemistry.
[114] M. Baldwin,et al. Characterization of the enzymatic specificity of the IGF-dependent insulin-like growth factor binding protein-4 (IGFBP-4) protease. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[115] D. Clemmons,et al. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I , 1993, The Journal of cell biology.
[116] D. Clemmons,et al. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions. , 1998, Endocrinology.
[117] D. Clemmons,et al. Tissue Transglutaminase Facilitates the Polymerization of Insulin-like Growth Factor-binding Protein-1 (IGFBP-1) and Leads to Loss of IGFBP-1's Ability to Inhibit Insulin-like Growth Factor-I-stimulated Protein Synthesis* , 2001, The Journal of Biological Chemistry.
[118] J. Wallace,et al. Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1. , 1989, The Biochemical journal.
[119] R. Baxter,et al. The role of glycosylation in the action of IGFBP-3. , 1995, Progress in growth factor research.
[120] C. Lang,et al. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus. , 1995, The Journal of clinical endocrinology and metabolism.
[121] S. Mohan,et al. Circulating levels of insulin-like growth factor-I and -II, and IGF-binding protein-3 in inflammation and after parathyroid hormone infusion. , 1994, Bone and mineral.
[122] R. Baxter. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. , 2000, American journal of physiology. Endocrinology and metabolism.
[123] D. Clemmons,et al. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. , 1992, Endocrinology.
[124] J. Fowlkes,et al. Characterization of Glycosaminoglycan-binding Domains Present in Insulin-like Growth Factor-binding Protein-3* , 1996, The Journal of Biological Chemistry.
[125] D. Clemmons. The Role of Insulin-Like Growth Factor Binding Proteins in Controlling the Expression of IGF Actions , 1989 .
[126] N. Ling,et al. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. , 1991, The Journal of biological chemistry.
[127] D. Andress. Comparison studies of IGFBP-5 binding to osteoblasts and osteoblast-derived extracellular matrix. , 1995, Progress in Growth Factor Research.
[128] M. Binoux,et al. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). , 1995, Endocrinology.
[129] S. Mohan,et al. Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. , 1995, The Journal of clinical endocrinology and metabolism.
[130] D. Clemmons,et al. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. , 1997, The Journal of clinical investigation.
[131] M. Binoux,et al. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action. , 1997, Endocrinology.
[132] R. Radulescu,et al. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. , 1997, Endocrinology.
[133] D. Clemmons,et al. Substitution of Specific Amino Acids in Insulin-like Growth Factor (IGF) Binding Protein 5 Alters Heparin Binding and Its Change in Affinity for IGF-I in Response to Heparin (*) , 1996, The Journal of Biological Chemistry.
[134] R. Baxter,et al. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. , 1992, Endocrinology.
[135] C. Renner,et al. Structure of the IGF‐binding domain of the insulin‐like growth factor‐binding protein‐5 (IGFBP‐5): implications for IGF and IGF‐I receptor interactions , 1998, The EMBO journal.
[136] T. Nam,et al. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I. , 1997, Endocrinology.
[137] Stephen Twigg,et al. Insulin-like Growth Factor (IGF)-binding Protein 5 Forms an Alternative Ternary Complex with IGFs and the Acid-labile Subunit* , 1998, The Journal of Biological Chemistry.
[138] R. Baxter,et al. Insulin-like Growth Factor-binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.
[139] W. A. Müller,et al. Non-suppressible insulin-like activity of human serum. II. Biological properties of plasma extracts with non-suppressible insulin-like activity. , 1966, Biochimica et biophysica acta.
[140] M. Rechler,et al. Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors. , 1988, Biochemical and biophysical research communications.
[141] D. Clemmons,et al. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. , 1990, Endocrinology.
[142] D. Clemmons,et al. Identification of the types of insulin-like growth factor-binding proteins that are secreted by muscle cells in vitro. , 1989, The Journal of biological chemistry.
[143] J R Yates,et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[144] L. Maile,et al. The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF)-independent effects of IGF-binding protein-3 on apoptosis in breast epithelial cells. , 1999, Endocrinology.
[145] R. Baxter,et al. Structural Determinants of Ligand and Cell Surface Binding of Insulin-like Growth Factor-binding Protein-3* , 1998, The Journal of Biological Chemistry.
[146] C. Conover,et al. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. , 1992, Endocrinology.
[147] D. Clemmons,et al. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin. , 1998, Endocrinology.
[148] D. Clemmons,et al. Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions. , 1988, The Journal of biological chemistry.
[149] K. Suzuki,et al. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. , 1994, The Journal of biological chemistry.
[150] T. Nam,et al. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. , 2000, Endocrinology.
[151] S. Mohan,et al. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. , 1994, Endocrinology.
[152] J. Clifford,et al. Direct Functional Interactions between Insulin-like Growth Factor-binding Protein-3 and Retinoid X Receptor-α Regulate Transcriptional Signaling and Apoptosis* , 2000, The Journal of Biological Chemistry.